Echelon Biosciences Inc. (EBI) is excited to announce a new partnership with ProBioscience Technologies for product distribution in Singapore and the Asia-Pacific region. Headquartered in Singapore, ProBioscience has partners, offices and/or labs in Singapore, Malaysia (Kuala Lumpur & Johor Bahru), Thailand, Myanmar and China and is committed to being a leading life science supplier for the Asian market.
“ProBioscience Technologies is a premier distributor of research and assay reagents for the Life Sciences community within Asia Pacific and now represents the full Echelon Biosciences product line.”, said Paul Neilsen, VP Business Development for EBI. “We are pleased to be working with them and look forward to a rewarding scientific relationship!”
Expansion of the Asian Life Sciences sector
The life sciences industry is witnessing rapid growth in the Asia-Pacific (APAC) region – home to 60 percent of the global population – due to increased R&D activity, a flow of mergers and acquisitions and market demand from several aging societies. Supported by these developments, the APAC biotech market is estimated to expand at a rapid compound annual growth rate of 16.8 percent up to 2028.
Echelon Biosciences is excited the opportunity to meet the growing scientific needs of the biological research community in Asia in 2022 and beyond.